Table 4.
Testing technologies | Potential markers | |
---|---|---|
MFC | CD2 | CD34 |
CD4 | CD45 | |
CD7 | CD56 | |
CD13 | CD123 | |
CD15 | CD117 | |
CD19 | HLA-DR | |
CD33 | ||
NGS | NPM1 | |
RUNX1 | ||
FLT3-ITD | ||
IDH1/IDH2 | ||
RT-qPCR | CBFB/MYH11 | |
FLT3-ITD | ||
IDH1/IDH2 | ||
NPM1 | ||
RUNX1/RUNX1T1 | ||
t(10;11) – KMT2A-MLLT10 | ||
t(11;19) – KMT2A-ELL or KMT2A-MLLT1 | ||
t(6;11) – KMT2A-MLLT4 | ||
t(9;11) – KMT2A-MLLT3 | ||
WT1 |
MLL/MLLT3, mixed lineage leukemia.